Several chemotherapeutic agents impair vascular endothelium, sympathetic nerve activity, and renin-angiotensin system activity, which makes hypertension the most common comorbidity associated with tumors (66), and some scholars have proposed the new concept of “onco-hypertension”. This evidence concerns the gene REN and Hypertension.